Boyer & Corporon Wealth Management, LLC Abb Vie Inc. Transaction History

Boyer & Corporon Wealth Management, LLC

$278 Million
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $4.29 Million - $5.45 Million	-31,144 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$131.98 - $163.75 $345,391 - $428,533	-2,617 Reduced 7.75%	31,144 $5.05 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $26,320 - $33,302	245 Added 0.73%	33,761 $4.57 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $41,921 - $47,587	394 Added 1.19%	33,516 $3.62 Million
Q2 2021 Aug 09, 2021	BUY	$105.21 - $117.21 $289,011 - $321,975	2,747 Added 9.04%	33,122 $3.73 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $293,805 - $323,444	-2,872 Reduced 8.64%	30,375 $3.29 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $85,641 - $115,624	1,064 Added 3.31%	33,247 $3.56 Million
Q3 2020 Nov 06, 2020	BUY	$85.91 - $100.83 $34,278 - $40,231	399 Added 1.26%	32,183 $2.82 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $317,178 - $424,432	-4,323 Reduced 11.97%	31,784 $3.12 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $29,347 - $44,494	-455 Reduced 1.24%	36,107 $2.75 Million
Q4 2019 Feb 06, 2020	BUY	$72.13 - $90.25 $31,304 - $39,168	434 Added 1.2%	36,562 $3.24 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $24,184 - $29,076	384 Added 1.07%	36,128 $2.74 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $416,340 - $532,181	6,337 Added 21.55%	35,744 $2.6 Million
Q1 2019 May 08, 2019	BUY	$77.14 - $90.79 $59,012 - $69,454	765 Added 2.67%	29,407 $2.37 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $343,863 - $424,076	4,417 Added 18.23%	28,642 $26.4 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $27,473 - $30,541	309 Added 1.29%	24,225 $2.26 Million
Q2 2018 Aug 08, 2018	BUY	$89.78 - $106.23 $2.15 Million - $2.54 Million	23,916 New	23,916 $2.22 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boyer & Corporon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boyer & Corporon Wealth Management, LLC with notifications on news.

Account